organization

IVI

INTERNATIONAL VACCINE INSTITUTE
  • project . 2009 - 2013
    Funder: EC Project Code: 241839
    Open Access mandate for Publications Special Clause 39
    Partners: University of Neuchâtel, IVI, SGUL, FIOCRUZ, SAMRC
  • project . 2019 - 2024
    Funder: EC Project Code: 815643
    Funder Contribution: 6,619,340 EUR
    Open Access mandate for Publications and Research Data
    Partners: THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE, EKUT, UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO, PAI Life Sciences (United States), GRAS, IVI, Texas Tech University System, UGOT, Leiden University Medical Center, University of Antananarivo

    Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomiasis-vaccine as one of the top-10 vaccines urgently needed. Chemotherapy is the preferred method for schistosomiasis control; but t...

  • project . 2016 - 2021
    Funder: EC Project Code: 734584
    Overall Budget: 12,556,100 EURFunder Contribution: 11,566,400 EUR
    Open Access mandate for Publications
    Partners: University of Glasgow, University of Valle, UU, FIOCRUZ, UNINORTE, SWISS TPH, ERASMUS MC, Institut Pasteur, LIAI, UOXF...

    The ZikaPLAN initiative combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centres in Europe to address the urgent research gaps (WP 1-8) in Zika, identifying short-and long term solutions (WP 9-10) and building a sustainabl...

  • project . 2010 - 2014
    Funder: EC Project Code: 241745
    Open Access mandate for Publications Special Clause 39
    Partners: ULB, UOXF, University of Ulm, CNRS, TBVI, Sciensano (Belgium), UZH, Institut Pasteur, EKUT, VWS...
Any information missing or wrong?Report an Issue